Canopy Growth (CGC): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
2 concentrated managers hold it (+1 vs last quarter) with a median weight of 0.0%.
Who owns Canopy Growth?
As of Jun 30, 2026, the largest holders reported on Form 13F were Tidal Investments (2.2% of the shares), Morgan Stanley (0.5%) and Lazard Asset Management (0.4%).
Which institutions hold the most Canopy Growth shares?
Per Form 13F filings as of Jun 30, 2026, as a share of all shares outstanding:
- 1. Tidal Investments: 2.2%
- 2. Morgan Stanley: 0.5%
- 3. Lazard Asset Management: 0.4%
- 4. Jane Street Group: 0.4%
- 5. UBS Group: 0.3%
- 6. Goldman Sachs Group: 0.3%
- 7. Susquehanna International Group, LLP: 0.3%
- 8. Royal Bank of Canada: 0.3%
- 9. National Bank of Canada: 0.2%
- 10. HRT Financial: 0.2%
How much of Canopy Growth do institutions own?
The 214 institutions that file 13F reported 7.0% of the shares as of Jun 30, 2026.
Sources:All of the company's proxy statements on EDGAR ↗
13F percentages divide the shares each institution reports by the shares outstanding on the cover of the company's latest report before the quarter end (Jun 11, 2026). Entities of the same group file separately and are not added up. We hold 13D and 13G filings made since December 2024: a holder above 5% that has not filed since then does not appear here.
Quarter flow (concentrated managers)
Change in managers (1 → 2): 1 opened · 0 exited = +1
Net flow in the quarter: +$0K (+178 shares) · bought $0K and sold $0Shares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.
Concentrated managers holding it
- GMT Capital$132K0.0%
- Skaana ManagementNew$1690.0%+0.0 pp
Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.
Largest holders of CGC (all 13F filers)
- Tidal Investments9.2 MInvestment firm+710 K
- Morgan Stanley1.9 MBank or trading desk−23 K
- Lazard Asset Management1.8 MInvestment firm+40 K
- Jane Street Group1.6 MBank or trading desk−20 K
- UBS Group1.4 MBank or trading desk+457 K
- Goldman Sachs Group1.3 MBank or trading desk+40 K
- Susquehanna International Group, LLP1.2 MBank or trading desk+239 K
- Royal Bank of Canada1.1 MBank or trading desk+106 K
- National Bank of Canada858 KBank or trading desk+48 K
- HRT Financial715 KBank or trading desk+397 K
- Shares
- 9.2 M
- Change
- +710 K
See more
- Type
- Investment firm
- Value
- $8.7M
- Shares
- 1.9 M
- Change
- −23 K
See more
- Type
- Bank or trading desk
- Value
- $1.8M
- Shares
- 1.8 M
- Change
- +40 K
See more
- Type
- Investment firm
- Value
- $1.8M
- Shares
- 1.6 M
- Change
- −20 K
See more
- Type
- Bank or trading desk
- Value
- $1.5M
- Shares
- 1.4 M
- Change
- +457 K
See more
- Type
- Bank or trading desk
- Value
- $1.3M
- Shares
- 1.3 M
- Change
- +40 K
See more
- Type
- Bank or trading desk
- Value
- $1.2M
- Shares
- 1.2 M
- Change
- +239 K
See more
- Type
- Bank or trading desk
- Value
- $1.2M
- Shares
- 1.1 M
- Change
- +106 K
See more
- Type
- Bank or trading desk
- Value
- $1.0M
- Shares
- 858 K
- Change
- +48 K
See more
- Type
- Bank or trading desk
- Value
- $816K
- Shares
- 715 K
- Change
- +397 K
See more
- Type
- Bank or trading desk
- Value
- $679K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Held by institutions (13F)
Institutions (13F): 7.0% of the shares · top 10: 5.0% · in index firms: 0.0% of the institutional total
Q2 2026: 7.0%
Shares reported by the 214 13F filers as of Jun 30, 2026, divided by the shares outstanding on the cover of the company's latest report (Jun 11, 2026). It is not all institutional ownership: only managers above $100M file a 13F, and it excludes short positions. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. We only publish it where the figure is credible: not for ADRs, companies with more than one share class or stale shares-outstanding data.
Insiders (Form 4)
10% owners who bought (6 m): 0
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
Flagged material events (8-K)
Notice of delisting or failure to meet a listing rule (Item 3.01)
Previously issued financial statements can no longer be relied on (Item 4.02)
«Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026»
Change of auditor (Item 4.01)
Unregistered sale of equity securities (Item 3.02)
«Canopy Growth Announces Strategic Recapitalization Transactions»
Unregistered sale of equity securities (Item 3.02)
«Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing…»
Change in directors or officers (Item 5.02)
«Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing…»
Alert items the company itself flagged in its 8-K filings with the SEC, most serious first. It is the form's label, with no interpretation from us: Item 5.02 covers routine appointments as well as a chief executive's departure; open the filing. The quoted headline is the original press release's.
All material events (8-K)
Earnings, agreements, financing, management changes and announcements from the last year, with a filter by type and a link to each filing.
Other Health Care stocks in managers' portfolios
Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.
- Agios PharmaceuticalsAGIO · 4 managers
- DavitaDVA · 4 managers
- KardiganKARD · 4 managers
- MapLight TherapeuticsMPLT · 4 managers
- Anteris Technologies GlobalAVR · 5 managers
- Compass TherapeuticsCMPX · 5 managers